CROMSOL

This brand name is authorized in Nigeria.

Active ingredients

The drug CROMSOL contains one active pharmaceutical ingredient (API):

1	Sodium cromoglicate UNII Q2WXR1I0PK - CROMOLYN SODIUM
	Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.
	Read more about Cromoglicic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-5725	Ear drops	CROMSOL Eye Drop Solution SOL_DROPS 100 mg 5ml,1X5ML	79 RNW-PP-161996 CROMSOL Eye Drop Solution CROMOLYN SODIUM Cromolyn Sodium USP 2%W/V, Cromoglicate Sodium 100mg, Sodium Chloride 27mg, Disodium Edetate 5mg, Bezalkonium Chloride Solution 1mg, Tween 800:005ml, Water for injection QS to 5ml B4-5725 Drugs Imported Products 5ml,15ML Prescription Only Medicine (POM) 9/16/2020 EXPHARLAB LIMITED, AGEGE MOTOR ROAD, MUSHIN LAGOS LAGOS 80332763 emmadanilozor@gmail.com AHLCON PARENTERALS (INDIA) LTD, SP-918, Phase III, Bhlwadi -301019, Distt, Alwar (Rajasthan) India., India	25/05/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01GX51	Cromoglicic acid, combinations	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-5725